SCHEMBL28338908

SCHEMBL28338908

COC(=O)Cc1cc(-c2cnc(C)nc2)cc2cn[nH]c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3C3 Q8NEB9 2/20 0.37
▸ RXRA P19793 1/20 0.37
▸ RXRB P28702 1/20 0.37
▸ RXRG P48443 1/20 0.37
▸ ROCK2 O75116 1/20 0.34
▸ HPGD P15428 2/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ POLQ O75417 1/20 0.33
▸ VEGFA P15692 1/20 0.33
▸ FLT1 P17948 1/20 0.33
▸ EGLN1 Q9GZT9 1/20 0.33
▸ EGLN3 Q9H6Z9 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ KDM4E B2RXH2 4/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ USP2 O75604 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20488360 0.81 KDM4E (0.37) PIK3C3RXRARXRBRXRGROCK2
SCHEMBL20487311 0.79 TSHR (0.42) PIK3C3RXRARXRBRXRGROCK2
SCHEMBL28340821 0.78 PRMT5 (0.37) HPGDVEGFAFLT1EGLN1EGLN3
SCHEMBL28340780 0.77 PRMT5 (0.36) HPGDVEGFAFLT1EGLN1EGLN3
SCHEMBL28338909 0.76 ACHE (0.39) PIK3C3RXRARXRBRXRGROCK2
SCHEMBL30125089 0.74 MEN1 (0.33) RXRARXRBRXRGHPGDEGLN1
SCHEMBL28937782 0.74 MEN1 (0.33) RXRARXRBRXRGHPGDEGLN1
SCHEMBL18555436 0.72 TRPA1 (0.50) PIK3C3RXRARXRBRXRGROCK2
SCHEMBL20488997 0.70 TRPA1 (0.39) RXRARXRBRXRGCYP1A2
SCHEMBL27395600 0.68 SMN1; SMN2 (0.39) ROCK2HPGDFLT1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110603252-A Aryl, heteroaryl and heterocyclic pharmaceutical compounds for the treatment of medical disorders 艾其林医药公司 2019-12-20 — — CN disclosed
Send feedback